Omega-3 marine triglycerides and Flonase drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Omega-3 marine triglycerides and Flonase. Common interactions include bone deformity among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people who take Omega-3 marine triglycerides and Flonase have. It is created by eHealthMe based on reports of 43 people who take Omega-3 marine triglycerides and Flonase from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

43 people who take Omega-3 marine triglycerides and Flonase together, and have interactions are studied.

What is Omega-3 marine triglycerides?

Omega-3 marine triglycerides has active ingredients of fish oil. eHealthMe is studying from 1,837 Omega-3 marine triglycerides users for its effectiveness, alternative drugs and more.

What is Flonase?

Flonase has active ingredients of fluticasone propionate. It is often used in allergies. eHealthMe is studying from 66,485 Flonase users for its effectiveness, alternative drugs and more.

Number of Omega-3 marine triglycerides and Flonase reports submitted per year:

Common Omega-3 Marine Triglycerides and Flonase drug interactions by gender *:

female:

Bone deformity
Constipation
Hyperhidrosis
Hypokalaemia
Muscle spasms
Pharyngitis
Respiratory tract infection
Cataract
Low turnover osteopathy
Tooth disorder

male:

Abdominal pain
Anaemia
Abnormal dreams
Angina unstable
Anorectal disorder
Anxiety
Arthralgia
Arthropathy
Ascites
Atrial fibrillation

Common Omega-3 Marine Triglycerides and Flonase drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Red blood cell count decreased

50-59:

Intervertebral disc protrusion
Leukocytosis
Nausea
Osteopenia
Rib fracture
Constipation
Hyperhidrosis
Hypertension
Hypokalaemia
Muscle spasms

60+:

Femur fracture
Low turnover osteopathy
Oedema peripheral
Pain in extremity
Pruritus
Asthma
Drug ineffective
Erythema
Fatigue
Gingival disorder

Common conditions people have *:

Osteoporosis (bones weak and more likely to break): 17 people, 39.53%
Hypersensitivity: 16 people, 37.21%
High Blood Pressure: 9 people, 20.93%
High Blood Cholesterol: 9 people, 20.93%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 8 people, 18.60%
Back Pain: 8 people, 18.60%
Sinus Disorder (disease of sinus): 7 people, 16.28%
Menopause (end of monthly cycles in women): 7 people, 16.28%
Osteopenia (a condition where bone mineral density is lower than normal): 6 people, 13.95%
Upper Respiratory Tract Infection: 5 people, 11.63%

* Approximation only. Some reports may have incomplete information.

Do you take Omega-3 marine triglycerides and Flonase?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .